Device
Omega
Omega is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_4
1
25%
Ph phase_3
1
25%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
completed375%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
completednot_applicable
Muscle Recovery After Omega-3 Supplementation
NCT07237113
recruitingnot_applicable
Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH
NCT04627701
completedphase_3
SGA-induced Metabolic Syndrome in Bipolar Youth
NCT01858948
completedphase_4
Vascular and Metabolic Effects of Omega-3 Fatty Acids
NCT01660932
Clinical Trials (4)
Showing 4 of 4 trials
NCT07237113Not Applicable
Muscle Recovery After Omega-3 Supplementation
NCT04627701Not Applicable
Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH
NCT01858948Phase 3
SGA-induced Metabolic Syndrome in Bipolar Youth
NCT01660932Phase 4
Vascular and Metabolic Effects of Omega-3 Fatty Acids
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4